Literature DB >> 19683034

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.

James C Vickers1, Anna E King, Adele Woodhouse, Matthew T Kirkcaldie, Jerome A Staal, Graeme H McCormack, Catherine A Blizzard, Ruth E J Musgrove, Stanislaw Mitew, Yao Liu, Jyoti A Chuckowree, Olivier Bibari, Tracey C Dickson.   

Abstract

There has been growing interest in the axon as the initial focus of pathological change in a number of neurodegenerative diseases of the central nervous system. This review concentrates on three major neurodegenerative conditions--amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease--with emphasis on key cellular changes that may underlie early axonal dysfunction and pathology and, potentially, the degeneration of neurons. In particular, this review will address recent data that indicate that the main pathological stimuli for these conditions, though often not definitively determined, result in an initial perturbation of the axon and its cytoskeleton, which then results in slow neuronal degeneration and loss of connectivity. The identification of a degenerative process initiated in the axon may provide new therapeutic targets for early intervention to inhibit the grim outcomes related to the progression of these diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19683034     DOI: 10.1016/j.brainresbull.2009.08.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  29 in total

1.  The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease.

Authors:  Ai-Wu Xiao; Jing He; Qian Wang; Yi Luo; Yan Sun; Yan-Ping Zhou; Yang Guan; Paul J Lucassen; Jia-Pei Dai
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

Review 2.  Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells.

Authors:  Silke Brunholz; Sangram Sisodia; Alfredo Lorenzo; Carole Deyts; Stefan Kins; Gerardo Morfini
Journal:  Exp Brain Res       Date:  2011-09-30       Impact factor: 1.972

3.  Sensory neuropathy attributable to loss of Bcl-w.

Authors:  Stephanie L Courchesne; Christoph Karch; Maria F Pazyra-Murphy; Rosalind A Segal
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

4.  Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

Authors:  Andreia Neves-Carvalho; Elsa Logarinho; Ana Freitas; Sara Duarte-Silva; Maria do Carmo Costa; Anabela Silva-Fernandes; Margarida Martins; Sofia Cravino Serra; André T Lopes; Henry L Paulson; Peter Heutink; João B Relvas; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2014-08-20       Impact factor: 6.150

5.  Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.

Authors:  Nichole D Hein; Shirley R Rainier; Rudy J Richardson; John K Fink
Journal:  Toxicol Lett       Date:  2010-09-17       Impact factor: 4.372

Review 6.  Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.

Authors:  Scott T Brady; Gerardo A Morfini
Journal:  Neurobiol Dis       Date:  2017-04-11       Impact factor: 5.996

Review 7.  Apoptosis versus axon pruning: Molecular intersection of two distinct pathways for axon degeneration.

Authors:  Matthew J Geden; Selena E Romero; Mohanish Deshmukh
Journal:  Neurosci Res       Date:  2018-11-16       Impact factor: 3.304

8.  Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis.

Authors:  Irene Guzmán-Soto; Eva Salinas; Irma Hernández-Jasso; J Luis Quintanar
Journal:  Neurochem Res       Date:  2012-07-26       Impact factor: 3.996

9.  Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.

Authors:  Angie C A Chiang; Stephanie W Fowler; Rohit Reddy; Olga Pletnikova; Juan C Troncoso; Mathew A Sherman; Sylvain E Lesne; Joanna L Jankowsky
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

10.  A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation.

Authors:  Malene Ambjørn; Véronique Dubreuil; Federico Miozzo; Fabienne Nigon; Bente Møller; Shohreh Issazadeh-Navikas; Jacob Berg; Michael Lees; Jan Sap
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.